SYK - Stryker Corporation

SYK

$305.09 2.54 (-0.83%) Last updated: May 31, 2026 05:53

52-Week Range

$305.09

$281.00 $305.09 $404.87

Fundamentals Overview

Stryker Corporation is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 35.3 PEG 2.11 P/B 5.24 P/S 4.63

Intrinsic value (DCF)

+9.5% upside vs price

Profitability

Net margin 13.2%

Risk (Beta)

0.81 — in line vol

Earnings & growth

EPS $8.63 Rev -16.1% Profit -12.2% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 52% confidence Risk: Moderate Volatility — Beta 0.81. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · Sentiment improving (1 upgrade)

Pressures (Sell):

3M vs S&P 500: -29.7% · 3M vs Healthcare sector: -15.3%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$116.96B

P/E (TTM)

35.34

EPS (TTM)

$8.63

Dividend Yield

1.13%

52-Week Range

$281.00 - $404.87

Volume vs Avg

N/A

Beta

0.81

About

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotech...

Sector: Healthcare

Headquarters: US

Employees: 53,000

IPO Date: Mar 1980

Website: www.stryker.com

Beta: 0.81 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 11, Hold: 6, Market Outperform: 1, Neutral: 3, Outperform: 4, Overweight: 5.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $333.96; current price is $305.09. That’s a +9.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	35.34
DCF value (model)	$333.96 (9.5% upside)
PEG (TTM)	2.11
P/B (TTM)	5.24
P/S (TTM)	4.63
P/FCF (TTM)	25.59
Liquidity & enterprise
Current Ratio (TTM)	2.11
Quick Ratio (TTM)	1.25
Cash Ratio (TTM)	0.46
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	13.21%
Gross margin (TTM)	63.67%
Operating margin (TTM)	21.34%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for SYK.

Analyst Sentiment at a Glance

B Sentiment Improving

Buy 11Hold 6Market Outperform 1Neutral 3Outperform 4Overweight 5

1 upgrade, 0 downgrades

Price Target Consensus

Current $305.09

Median $389.50

Consensus $385.83

Low consensus $315.00

High consensus $465.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Barclays	maintain	Overweight	Overweight	2026-05-04
Truist Securities	maintain	Hold	Hold	2026-05-04
JP Morgan	maintain	Overweight	Overweight	2026-05-01
Canaccord Genuity	maintain	Buy	Buy	2026-05-01
Wells Fargo	maintain	Overweight	Overweight	2026-05-01
Evercore ISI Group	maintain	Outperform	Outperform	2026-05-01
BTIG	maintain	Buy	Buy	2026-05-01
Needham	maintain	Buy	Buy	2026-05-01
Truist Securities	maintain	Hold	Hold	2026-04-15
BTIG	maintain	Buy	Buy	2026-04-14
Goldman Sachs	maintain	Neutral	Neutral	2026-04-09
Citigroup	maintain	Buy	Buy	2026-04-07
Evercore ISI Group	maintain	Outperform	Outperform	2026-04-06
UBS	maintain	Neutral	Neutral	2026-03-17
UBS	maintain	Neutral	Neutral	2026-02-24
BTIG	maintain	Buy	Buy	2026-01-30
Needham	maintain	Buy	Buy	2026-01-30
Bernstein	maintain	Outperform	Outperform	2026-01-09
Citizens	upgrade	Market Perform	Market Outperform	2025-12-19
Truist Securities	maintain	Hold	Hold	2025-12-18
Citigroup	maintain	Buy	Buy	2025-12-11
BTIG	maintain	Buy	Buy	2025-11-14
Wells Fargo	maintain	Overweight	Overweight	2025-11-14
Truist Securities	maintain	Hold	Hold	2025-11-14
Needham	maintain	Buy	Buy	2025-11-14
Truist Securities	maintain	Hold	Hold	2025-11-03
Evercore ISI Group	maintain	Outperform	Outperform	2025-10-31
BTIG	maintain	Buy	Buy	2025-10-31
Barclays	maintain	Overweight	Overweight	2025-10-22
Truist Securities	maintain	Hold	Hold	2025-10-15